International medical diagnostics company, Panbio Ltd (Panbio), has announced today that it has signed a Scheme Implementation Agreement with US company Inverness Medical Innovations, Inc. (AMEX: IMA), under which it is proposed that Inverness or its nominee will acquire all of the issued shares in Panbio for $0.65 cash per share pursuant to a scheme of arrangement (Scheme). If approved, the Scheme will apply to all issued Panbio Shares, including those held by employees under the employee share scheme.
